Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

My Strategy Since May 2017

Summary

Was over-cautious May 2017. Re-entered soon after.

Have secured profits on every concluded trade since then.

Expecting sizable biotech profits within 3 years.

Here is a summary of my concluded trades since May 2017:

AAOI at ave. $25.55 (Sold at 40.45 for 58.3 % profit = 109 % annualised

WFC at $53 (Sold at 58.85 for 11 % profit, = 26 % annualised)

BIIB at $288 (Sold at 344.70 for 19.7 % profit, = 31.5 % annualised)

P&G at $78.85 (Sold at 83.50 for 5.9 % profit, = 11 % annualised)

OMER at $13.85 (Sold at 22.28 for 61 % profit, = + 120 % annualised)

CELG at $76.20 (Sold at 87.50 for 15 % profit, = or 40 % annualised)

MRK at $54.85 (Sold at 76 for 38.6 % profit, = 51.5 % annualised)

TRIP at $40.85 (Sold at 58.55 for 43 % profit, = + 65 % annualised)

AZN at Pds 48.85 (Sold at Pds. 58.85 for 20.5 % profit, = 61 % annualised)

BMY at $54 (Sold at 60 for 11 % profit, = 33 % annualised)

XOM at $78 (Sold at 80 for small profit of 2.6 % or 10 % annualised)

RDS-B at Pds 22.20, sold 26.85 for 21 % profit, = 63 % annualised)

ARRY at $12.85 (Sold at 24.44 for 90 % profit, = 98 % annualised)

OPEN POSITIONS: I own 50 stocks (see previous thread for executions and dates). My positions (in order of today's value) are:

AFMD, AKCA, GOLD, CHL, ROCHE, QCOM, TENCENT, SAN, INCY, CS, CARA, FGEN, IONS, SNDX, FORMYCON, ABBV, HRTX, GILD, BLUE, ALXN, GHDX, BMRN, NVS, REGN, MU, ADMP, CELG, NFLX, MGI, PYPL, FB, LRCX, 1&1 DRILLISCH, TELEFONICA DEUTSCHLAND HOLDING, BAYER, CONTINENTAL AG, ACAD, GS, BMY, SRPT, ARNA, NVDA, VRTX, FATE, GE, PFNX, PFE, BABA, BBVA, CRM.

I am now 40 % invested, 60 % cash (half of which is parked in Swiss Gold ETFs). I shall keep trading with the stock portfolio, leaving the bulk of my funds for the crash, which fewer and fewer expect to occur in view of so many false alarms since the beginning of this bull market. Too many boiys crying 'wolf'. But the wolf will come, suddenly and swiftly. The market smells of bullish complacency.

Disclosure: I am/we are long 50 stocks.

Additional disclosure: The portfolio is heavily overweight biotech.